Oncology & Cancer

Late-stage ovarian cancer therapy shows promise in phase II trial

An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conducting a larger clinical trial ...

Oncology & Cancer

Researchers uncover key to greater efficacy in cancer treatment

Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy. In a Nature Communications paper published today, researchers ...

Oncology & Cancer

Alternative splicing, an important mechanism for cancer

Cancer, which is one of the leading causes of death worldwide, arises from the disruption of essential mechanisms of the normal cell life cycle, such as replication control, DNA repair and cell death. Thanks to the advances ...

Oncology & Cancer

Killer T cells get better with age, study finds

The human immune system is a thing of wonder. Up until now it had been widely assumed that the ability of killer T cells to destroy tumor cells and pathogens would deteriorate with age. It turns out, however, that the opposite ...

Medical research

Stressing cancer with spice

A new study by scientists in Japan and Indonesia reports how an experimental drug agent stops cancer cells from growing. A little over a decade ago, Indonesian scientists first reported pentagamavumon-1 (PGV-1), an analogue ...

Oncology & Cancer

New drug prevents spread of human prostate cancer cells

A new drug developed by Northwestern Medicine scientists prevented human prostate cancer cells from spreading to other tissues without any toxic effects to normal cells or tissues. The drug turns off the "go" switch in the ...

page 11 from 40